Current guidelines recommend anticoagulant therapy for 3-6 months following bioprosthetic valve replacement, including in patients with sinus rhythm, but only warfarin is recommended and approved ...
accelerated ventricular rhythm, and non-sustained uniform ventricular tachycardia. Frequent uniform PVCs were present in 6 pts and were completely suppressed during sinus tachycardia in 5/6.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback